|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase Ⅰtrial of weekly docetaxel (D) plus cisplatin in the treatment of advanced NSCLC in Chinese patients显示文摘 | Chu DT | 2002 | Proc Am Soc Clin Oncol2002，21，5： | 1 |
| 2 | The treatment of advanced non-small-cell lung Cancer (NSCLC) overseas updated and local experiences显示文摘 | Zhang XR Li JL | 2002 | Can To Kagaku ryoho2002，29，1： | 1 |
| 3 | Feasibility of morphologic assessment of vascular and biliary anatomy in pediatric liver transplantation:all-in-one protocol with breath-hold magnetic resonance显示文摘 | Chu WC Yeung DT Lee KH | 2005 | J Pediatr Surg2005，40，10： | 1 |
| 4 | Phase I trial of weekly docetaxel( D)plus cisplatin in the treatment of advanced NSCLC in Chinese patients 显示文摘 | Chu DT | 2002 | Proc Am Soc Clin Oncol2002，21，23： | 1 |
| 5 | Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland China 显示文摘 | Wu YL Chu DT Han B | 2012 | Asia-Pacific Journal of Clinical Oncology2012，8，3： | 1 |
| 6 | In vitro evaluation of ATT-719,a novel DNA gyrase inhibitor 显示文摘 | Flamm RK Vojtko C Chu DT | 1995 | Antimicrob Agents Chemother1995，39，8： | 1 |
| 7 | Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma显示文摘 | Mok TS Wu YL Thongprasert S Yang CH Chu DT Saijo N | | 0，，： | 1 |
| 8 | Synthesis and structure-activity relationships of new arylfluoronaphthyridine antibacterial agents显示文摘 | Chu DT Femandes PB Claibome AK | 1986 | J Med Chem1986，29，11： | 1 |
| 9 | Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinicallyselected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland China显示文摘 | Wu YL Chu DT Han B | 2012 | Asia Pac J C/in Oncol2012，8，3： | 1 |
| 10 | Monoclonal Antibidies-The new way to biologic therapy of tumor显示文摘 | Chu DT | 2004 | Chinese Journal of Oncology2004，26，3： | 1 |
| 11 | Natural killer cells utilize both pefforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver 显示文摘 | Loh J Chu DT O'Guin AK | 2005 | J Virol2005，79，1： | 1 |
| 12 | Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in TaiWan 显示文摘 | Chu NF Wang DT Shieh SM | 2000 | Int J Obes Relat Metab Disord2000，24，10： | 1 |
| 13 | Phase III, randomized, open-label, first-hne study in Asia of gefitinib versus carboplatin/pachtaxel in clinically selected patients with advanced non-small-cell lung cancer:evaluation of patients recruited from mainland China 显示文摘 | Wu YL Chu DT Han B | 2012 | Asia Pac J Clin Oncol2012，8，3： | 1 |
| 14 | Phase III,randomized,open-label,first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer:evaluation of patients recruited from mainland China显示文摘 | Wu YL Chu DT Han B | 2012 | Asia Pac J Clin Oncol2012，8，3： | 1 |
| 15 | The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration显示文摘 | Baird PN Guida E Chu DT Vu HT Guymer RH | | 0，，05： | 1 |
| 16 | Phase Ⅰ trial of weekly docetaxel (D) plus cisplatin(C) in the treatment of advanced NSCLC in Chinese patients显示文摘 | Chu DT | 2002 | Proc Am Soc Clin Oncol2002，21，： | 1 |
| 17 | The treatment of advanced non- small- cell lung Cancer (NSCLC)overseas updated and local experiences 显示文摘 | Chu DT Zhang XR Li JL | 2002 | Can To Kagaku ryoho2002，29，1： | 1 |
| 18 | The utility of a tissue slice model system to determine breast cancer infectivity by oncolytic adeno- viruses显示文摘 | Pennington K Chu QD Curiel DT | 2010 | J Surg Res2010，163，2： | 1 |
| 19 | In vitro evaluation of ABT-719,a novel DNA gyrase inhibitor显示文摘 | FLAMM RK VOJTKO C CHU DT | 1995 | Antimicrob Agents Chemother1995，39，4： | 1 |
| 20 | Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegaovirus infection in the spleen and liver 显示文摘 | Lob J Chu DT O' guin AK | 2005 | J Virol2005，79，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员